How have IDYA and RGC total returns compared?

Over the past 5 years, IDYA delivered 7.32% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

IDEAYA Biosciences, Inc. (IDYA) vs Regencell Bioscience Holdings Limited (RGC)

A side-by-side comparison of IDEAYA Biosciences, Inc. and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IDYA

IDEAYA Biosciences, Inc.

$3.48B

$36.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RGC

Regencell Bioscience Holdings Limited

$3.64B

$7.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — IDYA vs RGC

growth of $100 · dividends reinvested · last 5y

IDYA +103.9% (+15.3%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window

Log scale — wide-divergence pair

IDYA RGC

IDYA vs RGC: by the numbers

•RGC is the larger company ($3.64B vs $3.48B market cap).
•Both run net losses; RGC's is the smaller (0.00% vs -74.75% net margin).

Metrics side by side

Valuation

Metric	IDYA	RGC
P/S ratio	14.88	N/A
P/B ratio	2.91	2986.54

Profitability

Metric	IDYA	RGC
Gross margin	-43.89%	0.00%
Operating margin	-72.84%	0.00%
Net margin	-74.75%	0.00%
ROE	-14.60%	-73.75%
ROIC	-17.68%	-69.75%

Growth (annualized)

Metric	IDYA	RGC
Revenue CAGR (5Y)	45.80%	N/A
Total return CAGR (5Y)	7.32%	67.94%

Frequently asked

How have IDYA and RGC total returns compared?: Over the past 5 years, IDYA delivered 7.32% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IDYA analysis Full RGC analysis Interactive comparison tool

Dig into the metrics

IDEAYA Biosciences ROE Regencell Bioscience ROE IDEAYA Biosciences operating margin Regencell Bioscience operating margin IDEAYA Biosciences revenue growth Regencell Bioscience revenue growth IDEAYA Biosciences free cash flow Regencell Bioscience free cash flow

IDEAYA Biosciences & Regencell Bioscience appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.